Skip to main content

Table 2 Clinical characteristics of patients with choledochal cysts before surgery and healthy control children at various ages

From: The timing of minimally invasive surgery for prenatally diagnosed choledochal cysts

Age at surgery and group

Sex

(Male/Female, n)

Weight

(kg, M[P25,P75])

ALT

(U/L, M[P25,P75])

AST

(U/L, M[P25,P75])

aCholestasis

(Yes/No, n)

APRI

(M[P25,P75])

≤ 1 Month

CC (n = 15)

7/8

3.60[3.00,3.95]

12.00[5.00,16.00]

34.00[21.00,43.00]

7/8

0.30[0.19,0.90]

Control (n = 29)

8/21

3.80[3.45,4.35]

16.00[9.00,12.00]

31.00[22.00,42.50]

1/28

0.32[0.18,0.45]

p

0.206

0.056

0.104

0.921

0.002

0.465

1–2 Months

CC (n = 27)

7/20

4.50[4.00,4.80]

19.00[13.00,26.00]

31.00[25.00,44.00]

6/21

0.09[0.08,0.13]

Control (n = 20)

4/16

4.75[4.03,5.20]

20.00[16.50,31.75]

33.50[27.00,49.00]

0/20

0.11[0.06,0.19]

p

0.900

0.156

0.093

0.539

0.031

0.863

2–3 Months

CC (n = 14)

2/12

5.50[5.23,6.00]

40.50[27.00,90.75]

54.50[36.25,121.75]

3/11

0.16[0.09,0.44]

Control (n = 19)

6/13

5.90[5.15,6.30]

26.00[18.00,34.00]

36.00[27.00,48.00]

0/19

0.11[0.09,0.13]

p

0.416

0.265

0.013

0.035

0.067

0.045

> 3 Months

CC (n = 17)

1/16

7.00[6.35,7.90]

47.00[39.00,70.00]

59.00[42.00,87.50]

3/14

0.18[0.14,0.45]

Control (n = 17)

2/15

7.10[6.25,7.90]

31.00[27.00,36.50]

39.00[30.50,45.00]

0/17

0.13[0.10,0.16]

p

1.000

0.972

0.002

0.004

0.227

0.010

  1. a: There were no differences in the incidence of cholestasis among the 4 age groups at surgery (46.7% vs. 22.2% vs. 21.4% vs. 17.6%, p = 0.280)
  2. M indicates the median